Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Events symbols : RVNC save search
Revance to Present New DAXXIFY® Data at the American Academy of Neurology 2024 Annual Meeting
Published: 2024-04-12 (Crawled : 13:00) - biospace.com/
VTRS | $11.11 0.09% 0.09% 3.5M
|
Health Technology
|
| O: -0.17%
H: 0.17%
C: -1.9%
RVNC | $3.8 1.06% 1.05% 1.6M
|
Health Technology
|
| O: -2.01%
H: 1.37%
C: -5.92%
daxxify neurology meeting
Revance to Participate in the Guggenheim 6th Annual Biotechnology Conference
Published: 2024-02-01 (Crawled : 21:00) - biospace.com/
VTRS | $11.11 0.09% 0.09% 3.5M
|
Health Technology
|
| O: -0.42%
H: 1.75%
C: 1.28%
RVNC | $3.8 1.06% 1.05% 1.6M
|
Health Technology
|
| O: 1.59%
H: 4.11%
C: 0.78%
conference
Revance to Release Third Quarter 2023 Financial Results on Wednesday, November 8, 2023
Published: 2023-11-01 (Crawled : 13:00) - biospace.com/
VTRS | $11.11 0.09% 0.09% 3.5M
|
Health Technology
|
| O: -0.45%
H: 0.96%
C: 0.68%
RVNC | $3.8 1.06% 1.05% 1.6M
|
Health Technology
|
| O: -0.63%
H: 1.66%
C: 1.15%
financial results
Revance to Host Investor Day on September 19, 2023
Published: 2023-08-22 (Crawled : 14:00) - biospace.com/
VTRS | $11.11 0.09% 0.09% 3.5M
|
Health Technology
|
| O: -0.18%
H: 0.45%
C: -0.62%
RVNC | $3.8 1.06% 1.05% 1.6M
|
Health Technology
|
| O: 0.28%
H: 2.33%
C: 1.65%
day
Revance to Participate in Upcoming Investor Conferences - March 7, 2023
Published: 2023-03-07 (Crawled : 14:00) - biospace.com/
VTRS | $11.11 0.09% 0.09% 3.5M
|
Health Technology
|
| O: 0.09%
H: 0.18%
C: -1.29%
RVNC | $3.8 1.06% 1.05% 1.6M
|
Health Technology
|
| O: 0.36%
H: 0.69%
C: -0.6%
Revance to Participate in the 43rd Annual Cowen Healthcare Conference
Published: 2023-02-27 (Crawled : 14:00) - biospace.com/
VTRS | $11.11 0.09% 0.09% 3.5M
|
Health Technology
|
| O: -1.13%
H: 3.69%
C: -1.58%
RVNC | $3.8 1.06% 1.05% 1.6M
|
Health Technology
|
| O: 0.79%
H: 3.84%
C: 2.06%
conference
Revance to Present New Data on DAXXIFY® (DaxibotulinumtoxinA-lanm) for Injection for the Treatment of Cervical Dystonia at the Association of Academic Physiatrists Annual Meeting
Published: 2023-02-23 (Crawled : 15:00) - biospace.com/
VTRS | $11.11 0.09% 0.09% 3.5M
|
Health Technology
|
| O: 0.0%
H: 1.61%
C: 0.44%
RVNC | $3.8 1.06% 1.05% 1.6M
|
Health Technology
|
| O: 0.48%
H: 4.73%
C: 2.5%
daxxify treatment meeting association injection
Revance to Participate in the 34th Annual Piper Sandler Healthcare Conference
Published: 2022-11-22 (Crawled : 14:00) - biospace.com/
VTRS | $11.11 0.09% 0.09% 3.5M
|
Health Technology
|
| O: -1.35%
H: 1.46%
C: 1.19%
RVNC | $3.8 1.06% 1.05% 1.6M
|
Health Technology
|
| O: -0.14%
H: 3.44%
C: 2.76%
conference
Revance to Present Clinical Data on the Efficacy and Safety Profile of DAXXIFY™ (DaxibotulinumtoxinA-lanm) for Injection at the 2022 American Society for Dermatologic Surgery (ASDS) Annual Meeting
Published: 2022-10-10 (Crawled : 13:00) - biospace.com/
VTRS | $11.11 0.09% 0.09% 3.5M
|
Health Technology
|
| O: 0.92%
H: 0.57%
C: -0.79%
RVNC | $3.8 1.06% 1.05% 1.6M
|
Health Technology
|
| O: -0.27%
H: 0.0%
C: -1.37%
meeting injection lsd
Revance to Participate in the Guggenheim Nantucket Therapeutics Conference
Published: 2022-09-21 (Crawled : 13:20) - biospace.com/
VTRS | $11.11 0.09% 0.09% 3.5M
|
Health Technology
|
| O: 1.66%
H: 2.88%
C: -1.63%
RVNC | $3.8 1.06% 1.05% 1.6M
|
Health Technology
|
| O: 0.54%
H: 2.56%
C: -1.34%
conference therapeutics
Revance To Present Clinical Data on DaxibotulinumtoxinA for Injection at the 2022 TOXINS International Conference
Published: 2022-07-27 (Crawled : 13:00) - biospace.com/
RVNC | $3.8 1.06% 1.05% 1.6M
|
Health Technology
|
| O: 0.51%
H: 1.2%
C: 0.13%
conference injection international
Revance to Present Clinical Data on DaxibotulinumtoxinA for Injection and Hyaluronic Acid Filler Injection Technique at the 2021 American Society for Dermatologic Surgery (ASDS) Virtual Annual Meeting
Published: 2021-11-19 (Crawled : 14:00) - biospace.com/
RVNC | $3.8 1.06% 1.05% 1.6M
|
Health Technology
|
| O: -1.56%
H: 2.88%
C: -1.01%
injection lsd
Revance to Participate in the Stifel 2021 Virtual Healthcare Conference
Published: 2021-11-10 (Crawled : 23:00) - biospace.com/
RVNC | $3.8 1.06% 1.05% 1.6M
|
Health Technology
|
| O: 2.44%
H: 4.14%
C: 2.52%
conference
Revance to Showcase Data from Phase 3 ASPEN-1 Clinical Trial Evaluating Efficacy
Published: 2021-09-16 (Crawled : 13:00) - biospace.com/
RVNC | $3.8 1.06% 1.05% 1.6M
|
Health Technology
|
| O: -0.83%
H: 1.06%
C: 0.72%
phase 3 trial
Revance Presents Data on the RHA® Collection of Dermal Fillers at the 2021 Virtual Skin of Color Update Meeting
Published: 2021-09-10 (Crawled : 13:00) - biospace.com/
RVNC | $3.8 1.06% 1.05% 1.6M
|
Health Technology
|
| O: 0.54%
H: 0.46%
C: -3.14%
skin dermatitis
Revance to Release First Quarter 2021 Financial Results on Monday, May 10, 2021
Published: 2021-05-03 (Crawled : 13:00) - biospace.com/
RVNC | $3.8 1.06% 1.05% 1.6M
|
Health Technology
|
| O: 0.93%
H: 0.17%
C: -1.94%
financial results results ev
Revance to Highlight Aesthetic Clinical Data on DaxibotulinumtoxinA for Injection and Hyaluronic Acid Filler Study Results at Maui Derm for Dermatologists 2021
Published: 2021-01-25 (Crawled : 19:00) - biospace.com/
RVNC | $3.8 1.06% 1.05% 1.6M
|
Health Technology
|
| O: -0.38%
H: 1.02%
C: -0.81%
injection results
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.